1498 — PuraPharm Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for PuraPharm, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	68	91.4	59.7	75.8	20.1
Net Total Accounts Receivable
Net Total Receivables	231	222	300	156	113
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	598	608	611	486	350
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	413	554	492	431	397
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,222	1,375	1,206	1,016	844
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	639	592	665	665	571
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	860	863	804	758	691
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	362	512	402	258	153
Total Liabilities & Shareholders' Equity	1,222	1,375	1,206	1,016	844
Total Common Shares Outstanding